Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 16Leukemia, Myelomonocytic, Acute 11Leukemia, Monocytic, Acute 11Leukemia, Megakaryoblastic, Acute 11Leukemia, Erythroblastic, Acute 11Breast Neoplasms 9Congenital Abnormalities 8Glioblastoma 7Pancreatic Neoplasms 6Recurrence 5Leukemia, Myelomonocytic, Chronic 5Leukemia, Eosinophilic, Acute 5Leukemia, Basophilic, Acute 5Leukemia 5Gliosarcoma 5Anemia, Refractory, with Excess of Blasts 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Carcinoma, Non-Small-Cell Lung 4Brain Neoplasms 4Blast Crisis 4Urinary Bladder Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 3Squamous Cell Carcinoma of Head and Neck 3Multiple Myeloma 3Lung Neoplasms 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Inflammatory Breast Neoplasms 3Head and Neck Neoplasms 3Breast Neoplasms, Male 3Thyroid Neoplasms 2

Interventions

fludarabine phosphate 17Mycophenolic Acid 14Cyclophosphamide 14Whole-Body Irradiation 13Tacrolimus 11Peripheral Blood Stem Cell Transplantation 11Antilymphocyte Serum 11Busulfan 9Methotrexate 8Melphalan 7Filgrastim 7Cyclosporine 7Methylprednisolone 6thymoglobulin 5Stem Cell Transplantation 5Radiotherapy 5Thiotepa 4Cytarabine 4Antibodies 4fludarabine 3Transplantation 3Psychiatric Rehabilitation 3Isotretinoin 3Granulocyte Colony-Stimulating Factor 3Flow Cytometry 3Etoposide 3Cord Blood Stem Cell Transplantation 3Clofarabine 3Azacitidine 3Alemtuzumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Leukemia, Myelomonocytic, Juvenile × tipifarnib × Clear all
NCT00025038 2013-04-11

Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia

National Cancer Institute (NCI)

Phase 2 Completed
100 enrolled
Other hematologic neoplasm

Leukemia, Myelomonocytic, Juvenile

NCT00022451 2012-03-15

Tipifarnib in Treating Young Patients With Refractory Leukemia

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
LymphoidMyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡